Latest:
Dr Guerra on the Implications of a Study on Prostate Cancer Screening in Diverse Populations
Carmen Guerra, MD, MSCE, FACP, discusses the implications of research into the rates of prostate cancer screening in a population of diverse men.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Meredith Pelster, MD, MSCI
Latest:
Raising the Bar for KRAS G12C+ Colorectal Cancer Treatment
With 2 KRAS G12C inhibitors showing encouraging results in combination with anti-EGFR agents, there is a ray of hope for patients with recurrent colon cancer–a treatment that may offer patients the chance to make it to important milestones.
Rachel Offenbacher, MD
Rachel Offenbacher, MD, is an attending physician in the Division of Pediatric Hematology, Oncology, and Cellular Therapy Children’s Hospital at Montefiore. She is an assistant professor in the Department of Pediatrics at Albert Einstein College of Medicine and a member of Montefiore Einstein Comprehensive Cancer Center in Bronx, NY.
Latest:
From the Lab to the Clinic: Exploring DFMO’s Potential to Prevent Metastatic Disease in Children With Osteosarcoma and Ewing Sarcoma
DFMO shows promise in reducing metastasis in osteosarcoma and Ewing sarcoma, with phase 2 trials underway to test its role as maintenance therapy.
Jamie L. Studts, PhD
Latest:
How Behavioral Science Informs Empathetic and Effective Lung Cancer Prevention Strategies: With D. Ross Camidge, MD, PhD; and Jamie L. Studts, PhD
Drs Camidge and Studts discuss Dr Studts' career in behavioral science and the importance of integrating lung cancer screening into primary care.
Sharlene Gill, MD, MPH, MBA, FRCPC
Sharlene Gill, MD, MPH, MBA, FRCPC, is a professor in the Department of Medicine in the Division of Medical Oncology at The University of British Columbia in Canada.
Latest:
Dr Gill on a Survey of Patient Experiences and Involvement in Decision-Making in CRC
Sharlene Gill, BScPharm, MD, MPH, MBA, FRCPC, discusses patient experiences and involvement in decision-making in CRC.
Lia Gore, MD
Lia Gore, MD, is section head of Pediatric Hematology/Oncology/BMT, the Ergen Family Chair in Pediatric Oncology, and co-director of the Developmental Therapeutics Program at the University of Colorado Cancer Center, as well as a member of the Colorado Children's Hospital.
Latest:
Treatment Trends and Ongoing Research in Pediatric Acute Leukemia
Lia Gore, MD, and Sarah K. Tasian, MD, discuss ongoing research in pediatric acute leukemia.
Kaveh Zakeri, MD, MAS
Latest:
Treatment Paradigms Are Shifting for Locally Advanced HPV-Positive Head and Neck Cancers
A personalized treatment paradigm based on hypoxia imaging is promising and may yield a successful, personalized de-escalation strategy for patients with HPV-associated oropharynx cancer.
Matthew Lee, MD
Matthew Lee, MD, is an assistant professor in the Department of Medical Oncology and Therapeutics Research at the City of Hope in Duarte, California.
Latest:
Dr Lee on Disease-Free Survival Outcomes With Alectinib in ALK+ NSCLC
Matthew Lee, MD, details the improved disease-free survival outcomes with adjuvant alectinib in patients with ALK-positive NSCLC.
Bruce Brockstein, MD
Latest:
RP1: An Emerging Intratumoral Therapy
Panelists discuss the promising systemic responses of RP1, an oncolytic virus therapy for melanoma, emphasizing its expanded applicability through visceral tumor injection and the need for further data to optimize dosing strategies and confirm durability compared with other treatments.